A Feasibility study of alternate-day administrations of TS-1 as previously treated advanced non-small cell lung cancer in elderly patients
Latest Information Update: 24 Mar 2017
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary)
- Indications Non-small cell lung cancer
- Focus Adverse reactions
- 23 Mar 2017 Status changed from recruiting to completed.
- 24 Sep 2013 New trial record